MR-linac systems could help clinicians distinguish true progression from pseudoprogression in glioblastoma

Is it true progression or pseudoprogression in tumor growth?

Pomegranate seed oil boosts brain function in mild cognitive impairment study

Study demonstrates that pomegranate seed oil (PSO) combined with the Mediterranean Diet (MeDi) significantly enhances cognitive functions in individuals with mild cognitive impairment (MCI), suggesting

February 6, 2024

CureVac’s CVGBM Cancer Vaccine Induces Promising Immune Responses in Phase 1 Study in Glioblastoma Presented at the ESMO 2024 Congress – Biotech Investments

Issuer: CureVac / Key word(s): Conference/Study results 13.09.2024 / 13:57 CET/CEST The issuer is solely responsible for the content of this announcement. CureVac’s CVGBM Cancer

September 14, 2024

Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff

Researchers at the National Institutes of Health recently outlined strategies to tackle President Biden’s Cancer Moonshot initiative, which aims to cut cancer deaths in half

August 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.